Download PDF
Deutsche Zeitschrift für Onkologie 2016; 48(02): 48-54
DOI: 10.1055/s-0042-108141
Forschung
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Zwischen Anspruch und Wirklichkeit: Patientenkompetenz und Leitlinien-orientierte Medizin – ein Plädoyer

Nicole Weis
Further Information

Publication History

Publication Date:
13 July 2016 (online)

   Permissions and Reprints

Zusammenfassung

Leitlinien von Fachgesellschaften sind häufig Grundlage für Therapieentscheidungen. Wenn die Leitlinienempfehlungen nicht als Empfehlungen, sondern als Teil eines medizinisch unbestrittenen und dadurch notwendigen Behandlungskatalogs wahrgenommen werden, sind Konflikte zwischen Arzt und mündigem Patienten vorprogrammiert. Dieser Beitrag ist ein Plädoyer für eine menschliche und wirklich integrative Medizin am Beispiel der Brustkrebstherapie, indem mit der Patientin gemeinsam eine Entscheidung gefunden wird, auch wenn dies im Einzelfall bedeutet, dass Leitlinienempfehlungen aus individuellen Erwägungen heraus abgelehnt werden.

Summary

Expectations and reality: Patient competence and guideline-oriented medicine – a plea for humane and integrative medicine

Guidelines from expert organizations are often the basis of therapy decisions. However, in some cases, „guideline recommendations“ are not regarded as „recommendations“ but as part and parcel of undisputed medical and thus indispensable therapy catalogue. Such an approach is usually a recipe for conflict between the medical practitioner and the patient. This article serves as a plea for a humane and integrative medicine that uses breast cancer therapy as an example. In this context, the patient and the doctor jointly make a decision, even when in certain cases this implies that the guideline recommendations are rejected based on individual considerations.

Schlüsselwörter

Patientenkompetenz - Leitlinien - Mammakarzinom - onkologische Therapie - antihormonelle Therapie - Chemotherapie - Bestrahlung - Lymphonodektomie

Keywords

Patients competence - guidelines - breast cancer - oncological therapy - antihormons - chemotherapy - radiation therapy - lymphonodectomy
 

  • Literatur

  • 1 Badura B, Hart D, Schellschmidt H. Bürgerorientierung des Gesundheitswesens. Selbstbestimmung, Schutz, Beteiligung. Gutachten im Auftrag des Ministeriums für Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen. Mit Beiträgen von Bernhard Badura, Robert Francke, Winfried Göpfert, Dieter Hart, Ellis Huber, Germanus Hungeling, Christoph Kranich, Henner Schellschmidt und Franz Stuchlik. Baden-Baden: Nomos; 1999: 16
    Search in Google Scholar
  • 2 Ballard-Barbash R, Friedenreich CM, Courneya KS et al. Physical activity, biomarkers, and disease outcomes in cancer survivors: A systematic review. J Natl Cancer Inst 2012; 104(11): 815-40
    CrossrefPubMedSearch in Google Scholar
  • 03 Bijker N, Meijnen P, Peterse JL et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III Trial 10853—A study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006; 24: 3381-7
    CrossrefPubMedSearch in Google Scholar
  • 4 Bradshaw PT, Ibrahim JG, Khankari N et al. Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study. Breast Cancer Res Treat 2014; 145(3): 735-42
    CrossrefPubMedSearch in Google Scholar
  • 5 Cold S, Düring M, Ewertz M et al. Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG). Br J Cancer 2005; 93(6): 627-32
    CrossrefPubMedSearch in Google Scholar
  • 6 Cuzick J, Sestak I, Pinder SE et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ-DCIS-trial. Lancet Oncol 2011; 12: 21-9
    CrossrefPubMedSearch in Google Scholar
  • 7 Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Alencar VHM, Badran A. Bonfill X et al, for the Adjuvant Tamoxifen Longer Against Shorter (ATLAS) Collaborative Group. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. The Lancet 2013; 381(9869): 805-16
    CrossrefPubMedSearch in Google Scholar
  • 8 Deber RB, Kraetschmer N, Urowitz S, Sharpe N. Do people want to be autonomous patients? Preferred roles in treatment decision-making in several patient populations. Health Expect 2007; 10: 248-58
    CrossrefPubMedSearch in Google Scholar
  • 9 EBCTCG (Early Breast Cancer Trialists’ Collaborative Group). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. The Lancet 2014; 383: 2127-35
    CrossrefPubMedSearch in Google Scholar
  • 10 Ellis P, Barrett-Lee P, Johnson L et al. Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial. Lancet 2009; 373(9676): 1681-92
    CrossrefPubMedSearch in Google Scholar
  • 11 Giesen A et al. Körperliche Aktivität und Sport bei Mammakarzinom – ein Update. Dtsch Z Onkol 2015; 47: 100-4
    PubMedSearch in Google Scholar
  • 12 Giuliano AE, Hunt KK, Ballman KV et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 2011; 305(6): 569-75
    CrossrefPubMedSearch in Google Scholar
  • 13 Hall E et al. Comparison of patient reported quality of life and impact of treatment side effects experienced with a taxane-containing regimen and standard anthracycline based chemotherapy for early breast cancer: 6 year results from the UK TACT trial (CRUK/01/001). Eur J Cancer 2014; 50(14): 2375-89
    CrossrefPubMedSearch in Google Scholar
  • 14 https://idw-online.de/de/news639718
    PubMed
  • 15 Keisch M, Vicini F, Beitsch P et al. American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions. Am J Surg 2009; 198(4): 505-7
    CrossrefPubMedSearch in Google Scholar
  • 16 Keller-Matschke K. Und wo bleibt der Patient?. Dtsch Z Onkol 2012; 44: 178-9
    PubMedSearch in Google Scholar
  • 17 Klein F. Den Patienten als Partner sehen. Im Focus Onkologie 2015; 18(1–2): 12-5
    PubMedSearch in Google Scholar
  • 18 Kunkler I et al. The PRIME 2 trial: Avoiding radiotherapy is an option for some older patients with breast cancer. S2–01. 36th San Antonio Breast Cancer Symposium 10.-14.12.2013, San Antonio, SA
    PubMed
  • 19 Lattrich Claus. Therapie von Mammakarzinomen. TumorDiagn u Ther 2010; 31: 324-7
    Thieme ConnectPubMedSearch in Google Scholar
  • 20 Lehmann C, Koch U, Mehnert A. Die Bedeutung der Arzt-Patient-Kommunikation für die psychische Belastung und die Inanspruchnahme von Unterstützungsangeboten bei Krebspatienten: Ein Literaturüberblick über den gegenwärtigen Forschungsstand unter besonderer Berücksichtigung patientenseitiger Präferenzen. Psychother Psych Med 2009; 59: e3-e27
    Thieme ConnectPubMedSearch in Google Scholar
  • 21 Little P, Everitt H, Williamson I et al. Observational study of effect of patient centredness and positive approach on outcomes of general practice consultations. BMJ 2001; 323(7318): 908-11
    CrossrefPubMedSearch in Google Scholar
  • 22 Matthiessen PF. Leitlinien in der Onkologie – Pro & Contra. Dtsch Z Onkol 2004; 36: 135-7
    PubMedSearch in Google Scholar
  • 23 Möbus V. In: Kreienberg R, et al, eds. Mammakarzinom interdisziplinär. Berlin, Heidelberg: Springer; 2010: 181 Tab. 16.2, und 277–96
    Crossref
  • 24 Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011; 343: d5621
    CrossrefPubMedSearch in Google Scholar
  • 25 Neumaier J, Untch M. Taxan bei frühem Brustkrebs: Mehr Schaden als Nutzen?. ImFocus Onkologie 2015; 18(3): 32-3
    PubMedSearch in Google Scholar
  • 26 Palta M, Palta P, Bhavsar NA et al. The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: Changes in practice patterns after publication of Cancer and Leukemia Group B 9343. Cancer 2015; 121(2): 188-93
    CrossrefPubMedSearch in Google Scholar
  • 27 Platsch K-D. Die Medizin heilen. München: Systemische Medizin; 2014: 65
    Search in Google Scholar
  • 28 Roberts CS et al. Influence of physician communication on newly diagnosed breast cancer patients psychologic adjustment and decision-making. Cancer 1994; 74(1 Suppl): 336-41
    CrossrefPubMedSearch in Google Scholar
  • 29 Rudolph I et al. Der Informationsbedarf von Patienten. Dtsch Med Wochenschr 2015; 140: e43-e47
    Thieme ConnectPubMedSearch in Google Scholar
  • 30 Strnad V, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H on behalf of the Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO) et al. 5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial. The Lancet 2016; 387: 229-38
    CrossrefPubMedSearch in Google Scholar
  • 31 Vodermaier A. Prophylaktische Chirurgie bei Brust- und Eierstockkrebsrisiko aus psychologischer Perspektive. Dissertation. München: LMU München, Fakultät für Psychologie und Pädagogik; 2005
    PubMedSearch in Google Scholar
  • 32 Vodermaier A, Caspari C, Köhm J, Bauerfeind I, Kahlert S, Untch M. Shared decision-making in primary breast cancer. Z Ärztl Fortbild Qualitatssich 2004; Mar 98(2): 127-33
    PubMedSearch in Google Scholar
  • 33 Wärnberg F et al. Effect of Radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDICS Trial. J Clin Oncol 2014; 32(32): 3613-8
    CrossrefPubMedSearch in Google Scholar
  • 34 Williams PT. Significantly greater reduction in breast cancer mortality from post-diagnosis running than walking. Int J Cancer 2014; 135(5): 1195-202
    CrossrefPubMedSearch in Google Scholar